[
  {
    "ts": "2026-02-26T02:50:09+00:00",
    "headline": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
    "summary": "Pfizer Inc. (NYSE:PFE) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Pfizer Inc. (NYSE:PFE) with an Underperform rating and a $25 price target. The firm said its outlook reflects an “insurmountable” $15B-$20B revenue decline expected through 2030, with limited visibility into […]",
    "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ef4c3040-d87d-3ccf-9c6c-db8a9f6f2be0",
      "content": {
        "id": "ef4c3040-d87d-3ccf-9c6c-db8a9f6f2be0",
        "contentType": "STORY",
        "title": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Pfizer Inc. (NYSE:PFE) with an Underperform rating and a $25 price target. The firm said its outlook reflects an “insurmountable” $15B-$20B revenue decline expected through 2030, with limited visibility into […]",
        "pubDate": "2026-02-26T02:50:09Z",
        "displayTime": "2026-02-26T02:50:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e",
          "originalWidth": 1920,
          "originalHeight": 1275,
          "caption": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TkRKqkPAOo0eEJXaJY9Y2A--~B/aD0xMjc1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 1920,
              "height": 1275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pTG9ApYeTSmSfYp_rFmJ.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:00:00+00:00",
    "headline": "Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights",
    "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.",
    "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "adb71593-4a36-3dcc-ae54-ad496b7b3877",
      "content": {
        "id": "adb71593-4a36-3dcc-ae54-ad496b7b3877",
        "contentType": "STORY",
        "title": "Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights",
        "description": "",
        "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.",
        "pubDate": "2026-02-26T13:00:00Z",
        "displayTime": "2026-02-26T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0",
          "originalWidth": 400,
          "originalHeight": 176,
          "caption": "Novavax Logo (PRNewsfoto/Novavax)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lGAm3yWPXe2PzUrTUxfKZw--~B/aD0xNzY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 400,
              "height": 176,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1beS42kfkrJ3Bw2q.H.8UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "302440.KS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:46:00+00:00",
    "headline": "Novavax shares subdued despite earnings, revenue beat",
    "summary": "Investing.com -- Novavax Inc. (NASDAQ:NVAX) reported fourth quarter results that exceeded analyst expectations. Shares initially fell premarket, but now trade around 0.7% higher.",
    "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "6b2fd386-a5dd-325c-a1e7-acbabbfeaa4c",
      "content": {
        "id": "6b2fd386-a5dd-325c-a1e7-acbabbfeaa4c",
        "contentType": "STORY",
        "title": "Novavax shares subdued despite earnings, revenue beat",
        "description": "",
        "summary": "Investing.com -- Novavax Inc. (NASDAQ:NVAX) reported fourth quarter results that exceeded analyst expectations. Shares initially fell premarket, but now trade around 0.7% higher.",
        "pubDate": "2026-02-26T13:46:00Z",
        "displayTime": "2026-02-26T13:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]